Prostate-Specific Antigen Halving Time While on Neoadjuvant Androgen Deprivation Therapy Is Associated With Biochemical Control in Men Treated With Radiation Therapy for Localized Prostate Cancer-Reference-Cited by-同舟云学术

Prostate-Specific Antigen Halving Time While on Neoadjuvant Androgen Deprivation Therapy Is Associated With Biochemical Control in Men Treated With Radiation Therapy for Localized Prostate Cancer

Published:2011-03 Issue:4 Volume:79 Page:1022-1028
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Malik Renuka,Jani Ashesh B.,Liauw Stanley L.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference41 articles.

1. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer;D'Amico;J Clin Oncol,1999

2. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer;Kattan;J Clin Oncol,2003

3. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy;Stephenson;J Natl Cancer Inst,2006

4. Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer;Zelefsky;Urology,2007

5. Social Security Administration. Period Life Table. Available at: http://www.ssa.gov.OACT/STATS/table4c6.html. Last accessed Dec 3, 2009.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT;BMC Urology;2022-12-12

2. A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity;Cancer;2021-04-21

3. A prospective study of the effect of testosterone escape on preradiotherapy prostate-specific antigen kinetics in prostate cancer patients undergoing neoadjuvant androgen deprivation therapy;Current Urology;2021-03

4. Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation;Radiation Oncology;2017-09-07

5. American Cancer Society prostate cancer survivorship care guidelines;CA: A Cancer Journal for Clinicians;2014-06-10